Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling - Pozios, Ioannis; Seel, Nina N.; Hering, Nina A.; Hartmann, Lisa; Liu, Verena; Camaj, Peter; Müller, Mario H.; Lee, Lucas D.; Bruns, Christiane J.; Kreis, Martin E.; Seeliger, Hendrik (Cellular Oncology, 2021)